F

FBT

First Trust Amex Biotech Index Fund

222.7 4 USD

+0.66%

Сектор: Финансы

Базовая: USD

Валюта прибыли: USD

Дневной диапазон

Годовой диапазон

Дневное изменение

+0.66%

Месячное изменение

+10.29%

6-месячное изменение

+4.86%

Годовое изменение

+39.95%

Предыдущее закрытие

221.2 8

Open

222.8 1

Low

222.7 4

High

222.8 9

Volume

16

Открыть полный график Full chart

Обзор Все активы Тепловая карта

Ключевые активы Market Value Shares Weight %

Exact Sciences Corp 68.348 M 672.986 K 5.147%

ILMN Illumina Inc 54.872 M 418.360 K 4.132%

REGN Regeneron Pharmaceuticals Inc 53.672 M 69.535 K 4.041%

KRYS Krystal Biotech Inc 53.340 M 216.354 K 4.016%

NTRA Natera Inc 53.137 M 231.948 K 4.001%

BRKR Bruker Corp 52.427 M 1.113 M 3.948%

ACAD ACADIA Pharmaceuticals Inc 52.277 M 1.957 M 3.936%

VCYT Veracyte Inc 47.498 M 1.128 M 3.577%

BIIB Biogen Inc 47.143 M 267.876 K 3.550%

INCY Incyte Corp 46.276 M 468.520 K 3.485%

EXEL Exelixis Inc 45.123 M 1.030 M 3.398%

WAT Waters Corp 45.055 M 118.620 K 3.393%

BMRN BioMarin Pharmaceutical Inc 44.597 M 750.418 K 3.358%

RGEN Repligen Corp 44.296 M 270.328 K 3.335%

AMGN Amgen Inc 44.293 M 135.325 K 3.335%

VRTX Vertex Pharmaceuticals Inc 43.648 M 96.277 K 3.287%

UTHR United Therapeutics Corp 43.479 M 89.234 K 3.274%

MRNA Moderna Inc 43.155 M 1.463 M 3.250%

MTD Mettler-Toledo International I 42.977 M 30.826 K 3.236%

ARGX Argenx SE 41.432 M 49.268 K 3.120%

1
2

Новости

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Medical Technology Stocks: Innovation Endures As Valuations Reset

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil